目的探讨社区糖尿病患者的血糖控制及降糖药物使用。方法选取宿迁市宿城区项里街道项里社区卫生服务中心所下辖社区居民健康档案中的750例病程≥半年、年龄≥18岁的糖尿病患者为调查对象。采用自行设计的调查表对患者进行问卷调查,内容包括合并症、治疗、性别、服药情况、病程、年龄等。结果社区糖尿病患者应用磺脲类药物的比例最高,达66.0%;其次为双胍类(48.3%)、胰岛素制剂(10.2%)、中药制剂(8.5%)、α-糖苷酶抑制剂(6.6%)、胰岛素增敏剂(0.7%),最少的是药品成分不明确(0.4%)。社区糖尿病患者中有372例(54.8%)单用药物,有307例(45.2%)联用药物。结论应进一步加强社区医师糖尿病知识的培训,同时对社区糖尿病患者进行有针对性、有组织、有计划的健康教育,可有效提高患者的依从性,延缓和减少糖尿病并发症的发生。 Objective To investigate the glycemic control and the use of hypoglycemic drugs in community diabetic patients. Methods A total of 750 patients with diabetes mellitus of more than six months and ≥18 years of age were enrolled in the health records of community residents under Xiangjili Community Health Service Center, Suqian Sub-district, Suqian City. A self-designed questionnaire was used to conduct a questionnaire survey on patients, including complications, treatment, sex, medication, course of disease, age and so on. Results The prevalence of sulfonylurea was the highest in community-based diabetes patients (66.0%), followed by biguanides (48.3%), insulin preparations (10.2%), traditional Chinese medicine preparations (8.5%) and α-glucosidase inhibitors , Insulin sensitizer (0.7%), the least is the drug component is not clear (0.4%). There were 372 (54.8%) single-agent and 307 (45.2%) combination medications in community-based patients with diabetes. Conclusion It is necessary to further strengthen the training of community physicians on diabetes mellitus and to carry out targeted, organized and planned health education for community diabetes patients, which can effectively improve patient compliance and delay and reduce the incidence of diabetic complications.